Dual PI3K and Wnt pathway inhibition is a synergistic combination against triple negative breast cancer

Therapeutics: Dual therapy shrinks triple negative breast tumors Two experimental drugs currently in clinical trials as single agents might work better together against triple negative breast cancer. Jeffrey Solzak and Milan Radovich, and colleagues from the Indiana University School of Medicine in...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Jeffrey P. Solzak, Rutuja V. Atale, Bradley A. Hancock, Anthony L. Sinn, Karen E. Pollok, David R. Jones, Milan Radovich
Format: article
Langue:EN
Publié: Nature Portfolio 2017
Sujets:
Accès en ligne:https://doaj.org/article/4e107a1dad504786a827e6d2492a7acf
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!